Tctc Holdings, LLC Astrazeneca PLC Transaction History
Tctc Holdings, LLC
- $3.04 Billion
- Q2 2025
A detailed history of Tctc Holdings, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Tctc Holdings, LLC holds 300 shares of AZN stock, worth $22,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$22,602
Previous $22,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
501MCall Options Held
7.79MPut Options Held
2.48M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...